STADA is a public traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.  With sales of well over one billion Euros, STADA assists Britannia with both research and development support and financial investment.

An essential factor for the continued success of STADA’s business model is its individual market focus through the international network of local marketing and sales companies such as Britannia Pharmaceuticals in the UK. In order to rapidly adapt to individual country healthcare market changes, STADA’s local sales companies retain a high level of autonomy, allowing the flexibility to adapt and capitalise on local country market opportunities.